Transapical Redo-Aortic Valve in Valve Implantation With Left Main Protection Strategy

Transcatheter aortic valve implantation (TAVI) is mostly preferred for high-risk symptomatic group of patients with severe aortic stenosis. Surgical management of elderly patients with severe stenosis of bioprosthetic aortic valve (originally implanted 2005), coronary artery disease and porcelain aorta requiring redo-aortic valve replacement (AVR) with coronary artery bypass is not only associated with high morbidity and mortality but is challenging and requires accurate pre-planning. We report a successful combine transapical valve in valve implantation (TA-TAVI) with off pump coronary artery bypass grafting. Keywords: Bioprosthetic valve-stenosis; valve in valve implantation; Transapical; Off pump coronary artery by pass grafting; Porcelain aorta